Heart Disease News and Research

Latest Heart Disease News and Research

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

28 Mar 2011

Metagenics announces 2011 schedule for educational programs in lifestyle medicine

Metagenics Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, announced today the 2011 schedule for educational programs in lifestyle medicine as well as for certification programs for its FirstLine Therapy, a turnkey, lifestyle medicine program.

28 Mar 2011

Leicester professor receives Outstanding Alumni Achievement Award for Cardiovascular research

The winner of the University of Leicester inaugural Outstanding Alumni Achievement Award was revealed at the 2011 Alumni Black Tie Dinner on Thursday 17 February at the Mandarin Hotel in London.

28 Mar 2011

GE launches new specialty musculoskeletal MR scanner

GE today announced the launch of the Optima MR430s, a new specialty scanner with breakthrough technology that delivers precise imaging with exceptional comfort and the 1.5T image quality radiologists require.

28 Mar 2011

Drugs can prevent risk of breast cancer in women, experts say

Drugs could be used to prevent breast cancer in women at high risk of the disease in the same way that statins are used for heart disease if trials looking at ways of predicting risk are successful, according to an international panel of cancer experts.

28 Mar 2011

Toshiba introduces new Infinix-i cardiovascular X-ray systems

Accurately navigating and interpreting cardiovascular anatomy for precise device deployment is a challenge to physicians during complex interventional procedures. Providing physicians with greater confidence during these difficult procedures, Toshiba America Medical Systems, Inc. is introducing upgrades to its Infinix-i product line.

28 Mar 2011

CBAI partners with BlueCross and offers cord blood banking services to their members

Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.

28 Mar 2011

Study establishes strong link between nicotine and diabetes complications

Scientists today reported the first strong evidence implicating nicotine as the main culprit responsible for persistently elevated blood sugar levels - and the resulting increased risk of serious health complications - in people who have diabetes and smoke.

28 Mar 2011

Antioxidants in walnuts can reduce risk of heart disease

A new scientific study positions walnuts in the No. 1 slot among a family of foods that lay claim to being among Mother Nature's most nearly perfect packaged foods: Tree and ground nuts.

28 Mar 2011

New discovery may improve cochlear implants for deafness

University of Utah scientists used invisible infrared light to make rat heart cells contract and toadfish inner-ear cells send signals to the brain.

28 Mar 2011

Study finds only 1 in 10 children with asthma use traditional inhalers correctly

Fewer than one in 10 children with asthma use traditional inhalers correctly, according to a new study from the University of North Carolina at Chapel Hill.

28 Mar 2011

UT Southwestern receives $36.7 million CPRIT grant for cancer studies

The Cancer Prevention and Research Institute of Texas has awarded more than $36.7 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer investigators.

28 Mar 2011

People living at high altitudes have lower chance of dying from heart disease

In one of the most comprehensive studies of its kind, researchers at the University of Colorado School of Medicine in partnership with the Harvard School of Global Health have found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others.

28 Mar 2011

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.

28 Mar 2011

Diabetic smokers beware - Nicotine raises blood sugar: Study

U.S. researchers have found that nicotine in cigarettes may be responsible for serious complications in smokers with diabetes. They have shown that nicotine is strongly linked to persistently raised blood sugar levels among diabetics and scientists say they should make every effort to quit. There may also be implications for diabetics attempting to give up the habit who use nicotine-replacement therapy for extended periods.

27 Mar 2011

Walnuts best for heart when compared to other nuts

The latest research has shown that walnuts are the best nuts to prevent heart disease. Eating seven of the protein-rich walnuts a day could also help cut the risk of some cancers and type-2 diabetes say researchers. These nuts contain more antioxidants than almonds, Brazil nuts, cashews, hazelnuts, macadamias, peanuts, pecans and pistachios.

27 Mar 2011

Best thing to do when grieving is to help others

We all know celebrities. We tend to think of stars as part of our families. So when a famous person dies, grief is inevitable.

25 Mar 2011

Study finds increased risk of VTE during first year of combination oral contraceptive usage

Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill".

25 Mar 2011

FDA approves humanitarian device exemption for Elana Surgical Kit in cerebral bypass

Dutch medical device manufacturer, Elana bv, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a humanitarian device exemption (HDE), enabling a lifesaving cerebral bypass. Elana bv is a corporate spin-off from the University Medical Centre Utrecht, the Netherlands.

25 Mar 2011

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Teleflex Incorporated, a global provider of medical technology products, announced a global distribution agreement with Perouse Medical under which Teleflex will distribute the Perouse line of POLYSITE® intravenous implantable infusion ports.

25 Mar 2011